1. An overview on anti-tubulin agents for the treatment of lymphoma patients
   Marilia Barreca et al, 2020, Pharmacology & Therapeutics CrossRef
2. New tricks for old drugs: combination of rituximab and two nanoparticle-delivered chemotherapy drugs, albumin-bound paclitaxel and pegylated liposomal doxorubicin, in the treatment of relapsed/refractory diffuse large B cell lymphoma
   Liang Wang et al, 2020, Leukemia & Lymphoma CrossRef
3. RNA-seq and integrated network analysis reveals the hub genes and key pathway of paclitaxel inhibition on Adriamycin resistant diffuse large B cell lymphoma cells
   Haoyuan Hong et al, 2022, Bioengineered CrossRef
4. Overcoming physiological barriers by nanoparticles for intravenous drug delivery to the lymph nodes
   Noah Trac et al, 2021, Experimental Biology and Medicine CrossRef